Toronto Research Chemical
Toronto Research Chemicals (TRC), a subsidiary of the LGC Group, specializes in the manufacture of complex organic molecules and analytical standards for the biomedical research community. With decades of expertise, TRC has developed one of the most extensive catalogues in the industry, offering more than 350,000 products to support cutting-edge scientific research worldwide.
The portfolio is structured around several key categories. In research chemicals, TRC provides a vast selection including active pharmaceutical ingredients (APIs), bioactive molecules, building blocks, and other essential compounds. Its range of analytical standards covers impurities and metabolites critical for pharmaceutical and forensic analysis. TRC is also a leader in stable isotope-labelled compounds, particularly deuterium-enriched materials, serving areas such as proteomics, metabolomics, and biomedical studies. Beyond its catalogue, TRC offers custom synthesis services, designing and producing both novel and known compounds to meet specific customer requirements.
The applications of TRC’s products span diverse scientific disciplines: in pharmaceutical research, they support studies in cancer, infectious diseases, neurodegenerative and mental disorders, cardiovascular research, and toxicology; in forensic science, they enable research on controlled substances and other forensic targets; and in environmental studies, they contribute to the analysis of pollutants and environmental compounds.
